Abstract

Naturally occurring tumors in dogs are well-established models for several human cancers. Domestic cats share many of the benefits of dogs as a model (spontaneous cancers developing in an immunocompetent animal sharing the same environment as humans, shorter lifespan allowing more rapid trial completion and data collection, lack of standard of care for many cancers allowing evaluation of therapies in treatment-naïve populations), but have not been utilized to the same degree in the One Medicine approach to cancer. There are both challenges and opportunities in feline compared to canine models. This review will discuss three specific tumor types where cats may offer insights into human cancers. Feline oral squamous cell carcinoma is common, shares both clinical and molecular features with human head and neck cancer and is an attractive model for evaluating new therapies. Feline mammary tumors are usually malignant and aggressive, with the ‘triple-negative’ phenotype being more common than in humans, offering an enriched population in which to examine potential targets and treatments. Finally, although there is not an exact corollary in humans, feline injection site sarcoma may be a model for inflammation-driven tumorigenesis, offering opportunities for studying variations in individual susceptibility as well as preventative and therapeutic strategies.

Highlights

  • Occurring tumors in dogs are well-established models for several human cancers

  • Domestic cats have been used as models for various non-neoplastic diseases and are of particular value for investigation of inherited ophthalmic diseases and type 2 diabetes [1,2], to date the dog has been the focus in comparative oncology [3,4]

  • The cat may be superior to the dog as a model for some specific tumors, e.g., oral squamous cell carcinoma (SCC) and aggressive mammary tumors, due to the increased frequency in this species

Read more

Summary

Introduction

‘Cats are not small dogs’ is an oft-quoted phrase in veterinary medicine. Nowhere is this more true than in comparative oncology, and it is both the advantage and disadvantage of the cat as a model. Domestic cats have been used as models for various non-neoplastic diseases and are of particular value for investigation of inherited ophthalmic diseases and type 2 diabetes [1,2], to date the dog has been the focus in comparative oncology [3,4] This may be due, in part, to the fact that the complete feline genome has only very recently become available [5], whereas the canine genome has been available since 2005 [6]. The recently available feline genome may allow identification of genetic signatures of cancer risk in Siamese compared to other cats. Despite the potential challenges, investigating cancer in cats is likely to add to the field of comparative oncology and complement the use of the canine model, especially in some specific instances

Feline Oral Squamous Cell Carcinoma
Feline Mammary Gland Tumors
Injection Site Sarcoma
Findings
Conclusions

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.